Neurocrine Bioscience buy UBS Group AG
Start price
23.01.26
/
50%
€115.20
Target price
23.01.27
€151.53
Performance (%)
-9.24%
Price
13.02.26
€104.55
Summary
This prediction is currently active. With a performance of -9.24%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 23.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -12.474% |
| iShares Core DAX® | 1,93 % |
| iShares Nasdaq 100 | -0,18 % |
| iShares Nikkei 225® | 7,08 % |
| iShares S&P 500 | -0,20 % |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at UBS Group AG from $188.00 to $178.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.80
09.10.25
09.10.25
€167.52
09.10.26
09.10.26
-12.73%
13.02.26
13.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.95
09.07.25
09.07.25
€148.44
09.07.26
09.07.26
-8.25%
13.02.26
13.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€134.58
06.05.26
06.05.26
-3.33%
13.02.26
13.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.72
04.04.25
04.04.25
€123.79
04.04.26
04.04.26
20.56%
13.02.26
13.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-14.59%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25